Skip to content

Stereotaxis STXS Change in fair value of contingent consideration

Change in fair value of contingent consideration at other companies

Merit Medical Systems logo
Merit Medical SystemsMMSI
-$179K-117%
IAR
Integra LifeSciencesIART
-$1.29M-698%
TFX
TeleflexTFX
-$2.63M-46.6%

Other financials

Income statement

See full
Revenue$6.3M-15.8%
Gross profit$3.8M-6.6%
Operating income-$6.0M-0.9%
Net income-$5.9M-0.7%
EPS (diluted)-$0.06+14.3%

Balance sheet

See full
Cash & equivalents$14.6M+36.7%
Total debt$5.3M-10.0%
Total equity$14.4M+399%
Total assets$54.0M+18.2%

Cash flow

See full
Operating cash flow-$3.4M-93.5%
CapEx$79.0K
Free cash flow-$3.5M

Valuation

See full
Market cap$168.11M-11.6%
Enterprise value$158.77M-15.9%
P/S5.4×-0.6×

Profitability

See full
Gross margin53.9%+0.5pp
Operating margin-71%-14.0pp
Net margin-69.5%-13.7pp
FCF margin-35.5%-2.4pp

Returns & leverage

See full
Return on equity-251.5%-29.9pp
Debt / equity0.4×-1.7×
Current ratio1.6×+0.5×

Where this comes from

Reported directly by Stereotaxis in its filing.

Tagged under the XBRL concept us-gaap:BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1.

The official record: Stereotaxis’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stereotaxis's change in fair value of contingent consideration.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stereotaxis's change in fair value of contingent consideration?
Stereotaxis (STXS) reported change in fair value of contingent consideration of $756K in Q1 2026.
How has Stereotaxis's change in fair value of contingent consideration changed year-over-year?
Stereotaxis's change in fair value of contingent consideration increased by 50.6% year-over-year, from $502K to $756K.
What does change in fair value of contingent consideration mean?
This metric represents the non-cash adjustment to the estimated liability for potential future payments related to business acquisitions. It reflects changes in the fair value of earn-out provisions based on the probability of achieving specific performance milestones. Fluctuations in this value indicate shifts in management's outlook regarding the success of acquired assets.